Search results
Sep 1, 2023 · The SIG has updated its classification system and working definitions for variants of SARS-CoV-2, the virus that causes COVID-19, to better reflect the current variant landscape. The previous system classified all Omicron sublineages as part of the Omicron VOC and therefore did not provide the distinction needed to compare new descendent ...
Abstract. As of 25 January 2022, over 349 million individuals have received a confirmed diagnosis of covid-19, with over 5.59 million confirmed deaths associated with the SARS-CoV-2 virus. The covid-19 pandemic has prompted an extensive global effort to study the molecular evolution of the virus and develop vaccines to prevent its spread.
Mar 15, 2024 · SARS-CoV-2 (the virus that causes COVID-19) evolves over time, which results in a new strain (variant) of the virus. With COVID-19, new variants continue to emerge, with some variants disappearing while others will persist. The SARS-CoV-2 variants are classified into four groups: new variants of concern, variants of high consequence, variants being monitored and variants of interest. The AMA ...
The data we currently have available show us that COVID-19 vaccines are still very effective at preventing serious illness and death against all of the current variants of concern. Currently, the delta variant is dominant in the Americas and the rest of the world, and the WHO-approved COVID-19 vaccines are highly effective in protecting against ...
Dec 1, 2021 · New variants of COVID-19 continue to emerge. Some have evolved to be more transmissible while others have caused more severe illness. That's because the virus continues to change over time as it infects more people. Vaccination against COVID-19 continues to be the best way to protect yourself from severe illness, hospitalization, and death.
Jan 17, 2024 · COVID-19 is constantly evolving, with new variants and subvariants like delta, omicron, H.V.1 and E.G.5 emerging and peaking during respiratory season.
SARS-CoV-2 sequences by variant. School closures during the COVID-19 pandemic. Share of SARS-CoV-2 sequences that are the delta variant. Share of SARS-CoV-2 sequences that are the omicron variant. Share of global daily COVID-19 vaccine doses administered as boosters. Share of people who completed the initial COVID-19 vaccination protocol.
